Generalizable and transportable resting-state neural signatures characterized by functional networks, neurotransmitters, and clinical symptoms in autism.


Journal

Molecular psychiatry
ISSN: 1476-5578
Titre abrégé: Mol Psychiatry
Pays: England
ID NLM: 9607835

Informations de publication

Date de publication:
28 Sep 2024
Historique:
received: 10 11 2023
accepted: 19 09 2024
revised: 10 09 2024
medline: 29 9 2024
pubmed: 29 9 2024
entrez: 28 9 2024
Statut: aheadofprint

Résumé

Autism spectrum disorder (ASD) is a lifelong condition with elusive biological mechanisms. The complexity of factors, including inter-site and developmental differences, hinders the development of a generalizable neuroimaging classifier for ASD. Here, we developed a classifier for ASD using a large-scale, multisite resting-state fMRI dataset of 730 Japanese adults, aiming to capture neural signatures that reflect pathophysiology at the functional network level, neurotransmitters, and clinical symptoms of the autistic brain. Our adult ASD classifier was successfully generalized to adults in the United States, Belgium, and Japan. The classifier further demonstrated its successful transportability to children and adolescents. The classifier contained 141 functional connections (FCs) that were important for discriminating individuals with ASD from typically developing controls. These FCs and their terminal brain regions were associated with difficulties in social interaction and dopamine and serotonin, respectively. Finally, we mapped attention-deficit/hyperactivity disorder (ADHD), schizophrenia (SCZ), and major depressive disorder (MDD) onto the biological axis defined by the ASD classifier. ADHD and SCZ, but not MDD, were located proximate to ASD on the biological dimensions. Our results revealed functional signatures of the ASD brain, grounded in molecular characteristics and clinical symptoms, achieving generalizability and transportability applicable to the evaluation of the biological continuity of related diseases.

Identifiants

pubmed: 39342041
doi: 10.1038/s41380-024-02759-3
pii: 10.1038/s41380-024-02759-3
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Japan Agency for Medical Research and Development (AMED)
ID : JP18dm0307008
Organisme : Japan Agency for Medical Research and Development (AMED)
ID : JP23wm0625001
Organisme : Japan Agency for Medical Research and Development (AMED)
ID : JP24wm0625502
Organisme : Japan Agency for Medical Research and Development (AMED)
ID : JP18dm0307008
Organisme : Japan Agency for Medical Research and Development (AMED)
ID : JP19dm0207069
Organisme : Japan Agency for Medical Research and Development (AMED)
ID : JP18dm0307001
Organisme : Japan Agency for Medical Research and Development (AMED)
ID : JP18dm0307004
Organisme : Japan Agency for Medical Research and Development (AMED)
ID : JP18dm0307009
Organisme : Japan Agency for Medical Research and Development (AMED)
ID : JP18dm0307008
Organisme : Japan Agency for Medical Research and Development (AMED)
ID : JP24wm0625502
Organisme : Japan Agency for Medical Research and Development (AMED)
ID : JP18dm0307008
Organisme : Japan Agency for Medical Research and Development (AMED)
ID : JP24wm0625502
Organisme : Japan Agency for Medical Research and Development (AMED)
ID : JP18dm0307008
Organisme : Japan Agency for Medical Research and Development (AMED)
ID : JP24wm0625502
Organisme : Japan Agency for Medical Research and Development (AMED)
ID : JP24wm0625502
Organisme : MEXT | Japan Society for the Promotion of Science (JSPS)
ID : JP21H05171
Organisme : MEXT | Japan Society for the Promotion of Science (JSPS)
ID : JP21H05174

Informations de copyright

© 2024. The Author(s).

Références

Parellada M, Andreu-Bernabeu Á, Burdeus M, San José Cáceres A, Urbiola E, Carpenter LL, et al. In search of biomarkers to guide interventions in autism spectrum disorder: a systematic review. Am J Psychiatry. 2023;180:23–40.
pubmed: 36475375 doi: 10.1176/appi.ajp.21100992
Cortese S, Solmi M, Michelini G, Bellato A, Blanner C, Canozzi A, et al. Candidate diagnostic biomarkers for neurodevelopmental disorders in children and adolescents: a systematic review. World Psychiatry. 2023;22:129–49.
pubmed: 36640395 pmcid: 9840506 doi: 10.1002/wps.21037
Hallmayer J, Cleveland S, Torres A, Phillips J, Cohen B, Torigoe T, et al. Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry. 2011;68:1095–102.
pubmed: 21727249 pmcid: 4440679 doi: 10.1001/archgenpsychiatry.2011.76
Colvert E, Tick B, McEwen F, Stewart C, Curran SR, Woodhouse E, et al. Heritability of autism spectrum disorder in a UK population-based twin sample. JAMA Psychiatry. 2015;72:415–23.
pubmed: 25738232 pmcid: 4724890 doi: 10.1001/jamapsychiatry.2014.3028
Floris DL, Peng H, Warrier V, Lombardo MV, Pretzsch CM, Moreau C, et al. The link between autism and sex-related neuroanatomy, and associated cognition and gene expression. Am J Psychiatry. 2022;180:50–64. appiajp20220194
pubmed: 36415971 doi: 10.1176/appi.ajp.20220194
de Leeuw A, Happé F, Hoekstra RA. A conceptual framework for understanding the cultural and contextual factors on autism across the globe. Autism Res. 2020;13:1029–50.
pubmed: 32083402 pmcid: 7614360 doi: 10.1002/aur.2276
Fountain C, Winter AS, Bearman PS. Six developmental trajectories characterize children with autism. Pediatrics. 2012;129:e1112–e1120.
pubmed: 22473372 pmcid: 3340586 doi: 10.1542/peds.2011-1601
Waizbard-Bartov E, Ferrer E, Heath B, Rogers SJ, Nordahl CW, Solomon M, et al. Identifying autism symptom severity trajectories across childhood. Autism Res. 2022;15:687–701.
pubmed: 35084115 doi: 10.1002/aur.2674
Traut N, Heuer K, Lemaître G, Beggiato A, Germanaud D, Elmaleh M, et al. Insights from an autism imaging biomarker challenge: Promises and threats to biomarker discovery. Neuroimage. 2022;255:119171.
pubmed: 35413445 doi: 10.1016/j.neuroimage.2022.119171
Grove J, Ripke S, Als TD, Mattheisen M, Walters RK, Won H, et al. Identification of common genetic risk variants for autism spectrum disorder. Nat Genet. 2019;51:431–44.
pubmed: 30804558 pmcid: 6454898 doi: 10.1038/s41588-019-0344-8
Ho SY, Phua K, Wong L, Bin Goh WW. Extensions of the external validation for checking learned model interpretability and generalizability. Patterns (N Y). 2020;1:100129.
pubmed: 33294870 doi: 10.1016/j.patter.2020.100129
Feng W, Liu G, Zeng K, Zeng M, Liu Y. A review of methods for classification and recognition of ASD using fMRI data. J Neurosci Methods. 2021;368:109456.
pubmed: 34954253 doi: 10.1016/j.jneumeth.2021.109456
Horien C, Floris DL, Greene AS, Noble S, Rolison M, Tejavibulya L, et al. Functional connectome-based predictive modeling in autism. Biol Psychiatry. 2022;92:626–42.
pubmed: 35690495 pmcid: 10948028 doi: 10.1016/j.biopsych.2022.04.008
Wolfers T, Floris DL, Dinga R, van Rooij D, Isakoglou C, Kia SM, et al. From pattern classification to stratification: towards conceptualizing the heterogeneity of Autism Spectrum Disorder. Neurosci Biobehav Rev. 2019;104:240–54.
pubmed: 31330196 doi: 10.1016/j.neubiorev.2019.07.010
Santana CP, de Carvalho EA, Rodrigues ID, Bastos GS, de Souza AD, de Brito LL. rs-fMRI and machine learning for ASD diagnosis: a systematic review and meta-analysis. Sci Rep. 2022;12:6030.
pubmed: 35411059 pmcid: 9001715 doi: 10.1038/s41598-022-09821-6
Thompson WH, Wright J, Bissett PG, Poldrack RA. Dataset decay and the problem of sequential analyses on open datasets. Elife. 2020;9:e53498.
pubmed: 32425159 pmcid: 7237204 doi: 10.7554/eLife.53498
Spera G, Retico A, Bosco P, Ferrari E, Palumbo L, Oliva P, et al. Evaluation of altered functional connections in male children with autism spectrum disorders on multiple-site data optimized with machine learning. Front Psychiatry. 2019;10:620.
pubmed: 31616322 pmcid: 6763745 doi: 10.3389/fpsyt.2019.00620
Abraham A, Milham MP, Di Martino A, Craddock RC, Samaras D, Thirion B, et al. Deriving reproducible biomarkers from multi-site resting-state data: An Autism-based example. Neuroimage. 2017;147:736–45.
pubmed: 27865923 doi: 10.1016/j.neuroimage.2016.10.045
Yahata N, Morimoto J, Hashimoto R, Lisi G, Shibata K, Kawakubo Y, et al. A small number of abnormal brain connections predicts adult autism spectrum disorder. Nat Commun. 2016;7:11254.
pubmed: 27075704 pmcid: 4834637 doi: 10.1038/ncomms11254
Jahedi A, Nasamran CA, Faires B, Fan J, Müller R-A. Distributed intrinsic functional connectivity patterns predict diagnostic status in large autism cohort. Brain Connect. 2017;7:515–25.
pubmed: 28825309 pmcid: 5653144 doi: 10.1089/brain.2017.0496
Supekar K, Ryali S, Yuan R, Kumar D, de los Angeles C, Menon V. Robust, generalizable, and interpretable artificial intelligence–derived brain fingerprints of autism and social communication symptom severity. Biol Psychiatry. 2022;92:643–53.
pubmed: 35382930 pmcid: 9378793 doi: 10.1016/j.biopsych.2022.02.005
Degtiar I, Rose S. A review of generalizability and transportability. Ann Rev Stat Appl. 2023;10:501–24.
doi: 10.1146/annurev-statistics-042522-103837
Uddin LQ, Supekar K, Menon V. Reconceptualizing functional brain connectivity in autism from a developmental perspective. Front Hum Neurosci. 2013;7:458.
pubmed: 23966925 pmcid: 3735986 doi: 10.3389/fnhum.2013.00458
Alaerts K, Nayar K, Kelly C, Raithel J, Milham MP, Di Martino A. Age-related changes in intrinsic function of the superior temporal sulcus in autism spectrum disorders. Soc Cogn Affect Neurosci. 2015;10:1413–23.
pubmed: 25809403 pmcid: 4590540 doi: 10.1093/scan/nsv029
Wallace GL, Dankner N, Kenworthy L, Giedd JN, Martin A. Age-related temporal and parietal cortical thinning in autism spectrum disorders. Brain. 2010;133:3745–54.
pubmed: 20926367 pmcid: 2995883 doi: 10.1093/brain/awq279
Ilioska I, Oldehinkel M, Llera A, Chopra S, Looden T, Chauvin R, et al. Connectome-wide mega-analysis reveals robust patterns of atypical functional connectivity in autism. Biol Psychiatry. 2023;94:29–39.
Holiga Š, Hipp JF, Chatham CH, Garces P, Spooren W, D’Ardhuy XL, et al. Patients with autism spectrum disorders display reproducible functional connectivity alterations. Sci Transl Med. 2019;11:eaat9223.
pubmed: 30814340 doi: 10.1126/scitranslmed.aat9223
Nakamura K, Sekine Y, Ouchi Y, Tsujii M, Yoshikawa E, Futatsubashi M, et al. Brain serotonin and dopamine transporter bindings in adults with high-functioning autism. Arch Gen Psychiatry. 2010;67:59–68.
pubmed: 20048223 doi: 10.1001/archgenpsychiatry.2009.137
Garbarino VR, Gilman TL, Daws LC, Gould GG. Extreme enhancement or depletion of serotonin transporter function and serotonin availability in autism spectrum disorder. Pharmacol Res. 2019;140:85–99.
pubmed: 30009933 doi: 10.1016/j.phrs.2018.07.010
Jaiswal P, Mohanakumar KP, Rajamma U. Serotonin mediated immunoregulation and neural functions: Complicity in the aetiology of autism spectrum disorders. Neurosci Biobehav Rev. 2015;55:413–31.
pubmed: 26021727 doi: 10.1016/j.neubiorev.2015.05.013
Murayama C, Iwabuchi T, Kato Y, Yokokura M, Harada T, Goto T, et al. Extrastriatal dopamine D2/3 receptor binding, functional connectivity, and autism socio-communicational deficits: a PET and fMRI study. Mol Psychiatry. 2022;27:2106–13.
pubmed: 35181754 doi: 10.1038/s41380-022-01464-3
Buch AM, Vértes PE, Seidlitz J, Kim SH, Grosenick L, Liston C. Molecular and network-level mechanisms explaining individual differences in autism spectrum disorder. Nat Neurosci. 2023;26:650–63. 1–14
pubmed: 36894656 doi: 10.1038/s41593-023-01259-x
Aoki Y, Yoncheva YN, Chen B, Nath T, Sharp D, Lazar M, et al. Association of white matter structure with autism spectrum disorder and attention-deficit/hyperactivity disorder. JAMA Psychiatry. 2017;74:1120–8.
pubmed: 28877317 pmcid: 5710226 doi: 10.1001/jamapsychiatry.2017.2573
Ardesch DJ, Libedinsky I, Scholtens LH, Wei Y, van den Heuvel MP. Convergence of brain transcriptomic and neuroimaging patterns in schizophrenia, bipolar disorder, autism spectrum disorder, and major depressive disorder. Biol Psychiatry Cogn Neurosci Neuroimaging. 2023;8:630–9.
pubmed: 37286292
Thapar A, Cooper M, Rutter M. Neurodevelopmental disorders. Lancet Psychiatry. 2017;4:339–46.
pubmed: 27979720 doi: 10.1016/S2215-0366(16)30376-5
Yoshihara Y, Lisi G, Yahata N, Fujino J, Matsumoto Y, Miyata J, et al. Overlapping but asymmetrical relationships between schizophrenia and autism revealed by brain connectivity. Schizophr Bull. 2020. https://doi.org/10.1093/schbul/sbaa021 .
Lai M-C, Kassee C, Besney R, Bonato S, Hull L, Mandy W, et al. Prevalence of co-occurring mental health diagnoses in the autism population: a systematic review and meta-analysis. Lancet Psychiatry. 2019;6:819–29.
pubmed: 31447415 doi: 10.1016/S2215-0366(19)30289-5
Tanaka SC, Yamashita A, Yahata N, Itahashi T, Lisi G, Yamada T, et al. A multi-site, multi-disorder resting-state magnetic resonance image database. Sci Data. 2021;8:227.
pubmed: 34462444 pmcid: 8405782 doi: 10.1038/s41597-021-01004-8
Di Martino A, Yan C-G, Li Q, Denio E, Castellanos FX, Alaerts K, et al. The autism brain imaging data exchange: towards a large-scale evaluation of the intrinsic brain architecture in autism. Mol Psychiatry. 2014;19:659–67.
pubmed: 23774715 doi: 10.1038/mp.2013.78
Di Martino A, O’Connor D, Chen B, Alaerts K, Anderson JS, Assaf M, et al. Enhancing studies of the connectome in autism using the autism brain imaging data exchange II. Sci Data. 2017;4:170010.
pubmed: 28291247 pmcid: 5349246 doi: 10.1038/sdata.2017.10
Koike S, Tanaka SC, Okada T, Aso T, Yamashita A, Yamashita O, et al. Brain/MINDS beyond human brain MRI project: a protocol for multi-level harmonization across brain disorders throughout the lifespan. Neuroimage Clin. 2021;30:102600.
pubmed: 33741307 pmcid: 8209465 doi: 10.1016/j.nicl.2021.102600
Alexander LM, Escalera J, Ai L, Andreotti C, Febre K, Mangone A, et al. An open resource for transdiagnostic research in pediatric mental health and learning disorders. Sci Data. 2017;4:170181.
pubmed: 29257126 pmcid: 5735921 doi: 10.1038/sdata.2017.181
Esteban O, Markiewicz CJ, Blair RW, Moodie CA, Isik AI, Erramuzpe A, et al. fMRIPrep: a robust preprocessing pipeline for functional MRI. Nat Methods. 2019;16:111–6.
pubmed: 30532080 doi: 10.1038/s41592-018-0235-4
Dickie EW, Anticevic A, Smith DE, Coalson TS, Manogaran M, Calarco N, et al. Ciftify: a framework for surface-based analysis of legacy MR acquisitions. Neuroimage. 2019;197:818–26.
pubmed: 31091476 doi: 10.1016/j.neuroimage.2019.04.078
Power JD, Barnes KA, Snyder AZ, Schlaggar BL, Petersen SE. Spurious but systematic correlations in functional connectivity MRI networks arise from subject motion. Neuroimage. 2012;59:2142–54.
pubmed: 22019881 doi: 10.1016/j.neuroimage.2011.10.018
Glasser MF, Coalson TS, Robinson EC, Hacker CD, Harwell J, Yacoub E, et al. A multi-modal parcellation of human cerebral cortex. Nature. 2016;536:171–8.
pubmed: 27437579 pmcid: 4990127 doi: 10.1038/nature18933
Yeo BTT, Krienen FM, Sepulcre J, Sabuncu MR, Lashkari D, Hollinshead M, et al. The organization of the human cerebral cortex estimated by intrinsic functional connectivity. J Neurophysiol. 2011;106:1125–65.
pubmed: 21653723 doi: 10.1152/jn.00338.2011
Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2007;8:118–27.
pubmed: 16632515 doi: 10.1093/biostatistics/kxj037
Ichikawa N, Lisi G, Yahata N, Okada G, Takamura M, Hashimoto R-I, et al. Primary functional brain connections associated with melancholic major depressive disorder and modulation by antidepressants. Sci Rep. 2020;10:3542.
pubmed: 32103088 pmcid: 7044159 doi: 10.1038/s41598-020-60527-z
Yamashita A, Sakai Y, Yamada T, Yahata N, Kunimatsu A, Okada N, et al. Generalizable brain network markers of major depressive disorder across multiple imaging sites. PLoS Biol. 2020;18:e3000966.
pubmed: 33284797 pmcid: 7721148 doi: 10.1371/journal.pbio.3000966
Almuqhim F, Saeed F. ASD-SAENet: a sparse autoencoder, and deep-neural network model for detecting autism spectrum disorder (ASD) using fMRI data. Front Comput Neurosci. 2021;15:654315.
pubmed: 33897398 pmcid: 8060560 doi: 10.3389/fncom.2021.654315
Kwon H, Kim JI, Son S-Y, Jang YH, Kim B-N, Lee HJ, et al. Sparse Hierarchical Representation Learning on Functional Brain Networks for Prediction of Autism Severity Levels. Front Neurosci. 2022;16:935431.
pubmed: 35873817 pmcid: 9301472 doi: 10.3389/fnins.2022.935431
Tibshirani R. Regression shrinkage and selection via the lasso. J R Stat Soc. 1996;58:267–88.
doi: 10.1111/j.2517-6161.1996.tb02080.x
Chicco D. Ten quick tips for machine learning in computational biology. BioData Min. 2017;10:35.
pubmed: 29234465 pmcid: 5721660 doi: 10.1186/s13040-017-0155-3
Holm S. A simple sequentially rejective multiple test procedure. Scand Stat Theory Appl. 1979;6:65–70.
Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc. 1995;57:289–300.
doi: 10.1111/j.2517-6161.1995.tb02031.x
Schaefer A, Kong R, Gordon EM, Laumann TO, Zuo X-N, Holmes AJ, et al. Local-global parcellation of the human cerebral cortex from intrinsic functional connectivity MRI. Cereb Cortex. 2018;28:3095–114.
pubmed: 28981612 doi: 10.1093/cercor/bhx179
Lake EMR, Finn ES, Noble SM, Vanderwal T, Shen X, Rosenberg MD, et al. The functional brain organization of an individual allows prediction of measures of social abilities transdiagnostically in autism and attention-deficit/hyperactivity disorder. Biol Psychiatry. 2019;86:315–26.
pubmed: 31010580 pmcid: 7311928 doi: 10.1016/j.biopsych.2019.02.019
Markello RD, Hansen JY, Liu Z-Q, Bazinet V, Shafiei G, Suárez LE, et al. neuromaps: structural and functional interpretation of brain maps. Nat Methods. 2022;19:1472–9.
pubmed: 36203018 pmcid: 9636018 doi: 10.1038/s41592-022-01625-w
Hansen JY, Shafiei G, Markello RD, Smart K, Cox SML, Nørgaard M, et al. Mapping neurotransmitter systems to the structural and functional organization of the human neocortex. Nat Neurosci. 2022. https://doi.org/10.1038/s41593-022-01186-3 .
Yamashita M, Kawato M, Imamizu H. Predicting learning plateau of working memory from whole-brain intrinsic network connectivity patterns. Sci Rep. 2015;5:7622.
pubmed: 25557398 pmcid: 5154600 doi: 10.1038/srep07622
Scheinost D, Noble S, Horien C, Greene AS, Lake EM, Salehi M, et al. Ten simple rules for predictive modeling of individual differences in neuroimaging. Neuroimage. 2019;193:35–45.
pubmed: 30831310 doi: 10.1016/j.neuroimage.2019.02.057
Kazeminejad A, Sotero RC. Topological properties of resting-state fMRI functional networks improve machine learning-based autism classification. Front Neurosci. 2018;12:1018.
pubmed: 30686984 doi: 10.3389/fnins.2018.01018
Lanka P, Rangaprakash D, Dretsch MN, Katz JS, Denney TS Jr, Deshpande G. Supervised machine learning for diagnostic classification from large-scale neuroimaging datasets. Brain Imaging Behav. 2020;14:2378–416.
pubmed: 31691160 pmcid: 7198352 doi: 10.1007/s11682-019-00191-8
Padmanabhan A, Lynn A, Foran W, Luna B, O’Hearn K. Age related changes in striatal resting state functional connectivity in autism. Front Hum Neurosci. 2013;7:814.
pubmed: 24348363 pmcid: 3842522 doi: 10.3389/fnhum.2013.00814
Cerliani L, Mennes M, Thomas RM, Di Martino A, Thioux M, Keysers C. Increased functional connectivity between subcortical and cortical resting-state networks in autism spectrum disorder. JAMA Psychiatry. 2015;72:767–77.
pubmed: 26061743 pmcid: 5008437 doi: 10.1001/jamapsychiatry.2015.0101
Park S, Haak KV, Cho HB, Valk SL, Bethlehem RAI, Milham MP, et al. Atypical integration of sensory-to-transmodal functional systems mediates symptom severity in autism. Front Psychiatry. 2021;12:699813.
pubmed: 34489757 pmcid: 8417581 doi: 10.3389/fpsyt.2021.699813
Hong S-J, Vos de Wael R, Bethlehem RAI, Lariviere S, Paquola C, Valk SL, et al. Atypical functional connectome hierarchy in autism. Nat Commun. 2019;10:1022.
pubmed: 30833582 pmcid: 6399265 doi: 10.1038/s41467-019-08944-1
Yerys BE, Gordon EM, Abrams DN, Satterthwaite TD, Weinblatt R, Jankowski KF, et al. Default mode network segregation and social deficits in autism spectrum disorder: Evidence from non-medicated children. Neuroimage Clin. 2015;9:223–32.
pubmed: 26484047 pmcid: 4573091 doi: 10.1016/j.nicl.2015.07.018
Muller CL, Anacker AMJ, Veenstra-VanderWeele J. The serotonin system in autism spectrum disorder: from biomarker to animal models. Neuroscience. 2016;321:24–41.
pubmed: 26577932 doi: 10.1016/j.neuroscience.2015.11.010
Hamilton PJ, Campbell NG, Sharma S, Erreger K, Herborg Hansen F, Saunders C, et al. De novo mutation in the dopamine transporter gene associates dopamine dysfunction with autism spectrum disorder. Mol Psychiatry. 2013;18:1315–23.
pubmed: 23979605 pmcid: 4046646 doi: 10.1038/mp.2013.102
Kaneko A, Ohshima R, Noda H, Matsumaru T, Iwanaga R, Ide M. Sensory and social subtypes of Japanese individuals with autism spectrum disorders. 2023;53:3133–43.
Thye MD, Bednarz HM, Herringshaw AJ, Sartin EB, Kana RK. The impact of atypical sensory processing on social impairments in autism spectrum disorder. Dev Cogn Neurosci. 2018;29:151–67.
pubmed: 28545994 doi: 10.1016/j.dcn.2017.04.010
Cross-Disorder Group of the Psychiatric Genomics Consortium. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet. 2013;381:1371–9.
pmcid: 3714010 doi: 10.1016/S0140-6736(12)62129-1
Chen H, Uddin LQ, Duan X, Zheng J, Long Z, Zhang Y, et al. Shared atypical default mode and salience network functional connectivity between autism and schizophrenia. Autism Res. 2017;10:1776–86.
pubmed: 28730732 pmcid: 5685899 doi: 10.1002/aur.1834
Oliver LD, Moxon-Emre I, Lai M-C, Grennan L, Voineskos AN, Ameis SH. Social cognitive performance in schizophrenia spectrum disorders compared with autism spectrum disorder: a systematic review, meta-analysis, and meta-regression. JAMA Psychiatry. 2021;78:281–92.
pubmed: 33291141 doi: 10.1001/jamapsychiatry.2020.3908
Jutla A, Foss-Feig J, Veenstra-VanderWeele J. Autism spectrum disorder and schizophrenia: an updated conceptual review. Autism Res. 2022;15:384–412.
pubmed: 34967130 doi: 10.1002/aur.2659
Hong S-J, Valk SL, Di Martino A, Milham MP, Bernhardt BC. Multidimensional neuroanatomical subtyping of autism spectrum disorder. Cereb Cortex. 2018;28:3578–88.
pubmed: 28968847 doi: 10.1093/cercor/bhx229
Urchs SGW, Tam A, Orban P, Moreau C, Benhajali Y, Nguyen HD, et al. Functional connectivity subtypes associate robustly with ASD diagnosis. Elife. 2022;11:e56257.
pubmed: 36444973 pmcid: 9708070 doi: 10.7554/eLife.56257
Tang S, Sun N, Floris DL, Zhang X, Di Martino A, Yeo BTT. Reconciling dimensional and categorical models of autism heterogeneity: a brain connectomics and behavioral study. Biol Psychiatry. 2020;87:1071–82.
pubmed: 31955916 doi: 10.1016/j.biopsych.2019.11.009
Tung Y-H, Lin H-Y, Chen C-L, Shang C-Y, Yang L-Y, Hsu Y-C, et al. Whole brain white matter tract deviation and idiosyncrasy from normative development in autism and ADHD and unaffected siblings link with dimensions of psychopathology and cognition. Am J Psychiatry. 2021;178:730–43.
pubmed: 33726525 doi: 10.1176/appi.ajp.2020.20070999
Benkarim O, Paquola C, Park B-Y, Hong S-J, Royer J, Vos de Wael R, et al. Connectivity alterations in autism reflect functional idiosyncrasy. Communications Biology. 2021;4:1–15.
doi: 10.1038/s42003-021-02572-6
Hahamy A, Behrmann M, Malach R. The idiosyncratic brain: distortion of spontaneous connectivity patterns in autism spectrum disorder. Nat Neurosci. 2015;18:302–9.
pubmed: 25599222 doi: 10.1038/nn.3919
Dinga R, Schmaal L, Penninx BWJH, van Tol MJ, Veltman DJ, van Velzen L, et al. Evaluating the evidence for biotypes of depression: methodological replication and extension of. Neuroimage Clin. 2019;22:101796.
pubmed: 30935858 pmcid: 6543446 doi: 10.1016/j.nicl.2019.101796
Yamada T, Hashimoto R-I, Yahata N, Ichikawa N, Yoshihara Y, Okamoto Y, et al. Resting-state functional connectivity-based biomarkers and functional MRI-based neurofeedback for psychiatric disorders: a challenge for developing theranostic biomarkers. Int J Neuropsychopharmacol. 2017;20:769–81.
pubmed: 28977523 pmcid: 5632305 doi: 10.1093/ijnp/pyx059
Christensen DL, Braun KVN, Baio J, Bilder D, Charles J, Constantino JN, et al. Prevalence and characteristics of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2012. MMWR Surveill Summ. 2018;65:1–23.
pubmed: 30439868 pmcid: 6237390 doi: 10.15585/mmwr.ss6513a1
Reiter MA, Mash LE, Linke AC, Fong CH, Fishman I, Müller R-A. Distinct patterns of atypical functional connectivity in lower-functioning autism. Biol Psychiatry Cogn Neurosci Neuroimaging. 2019;4:251–9.
pubmed: 30343132
Whelan R, Garavan H. When optimism hurts: inflated predictions in psychiatric neuroimaging. Biol Psychiatry. 2014;75:746–8.
pubmed: 23778288 doi: 10.1016/j.biopsych.2013.05.014

Auteurs

Takashi Itahashi (T)

Medical Institute of Developmental Disabilities Research, Showa University, Tokyo, Japan.

Ayumu Yamashita (A)

Brain Information Communication Research Laboratory Group, Advanced Telecommunications Research Institute International, Kyoto, Japan.
Graduate School of Information Science and Technology, The University of Tokyo, Tokyo, Japan.

Yuji Takahara (Y)

Brain Information Communication Research Laboratory Group, Advanced Telecommunications Research Institute International, Kyoto, Japan.
Drug Discovery Research Division, Shionogi & Co., Ltd., Osaka, Japan.

Noriaki Yahata (N)

Brain Information Communication Research Laboratory Group, Advanced Telecommunications Research Institute International, Kyoto, Japan.
Institute for Quantum Life Science, National Institutes for Quantum Science and Technology, Chiba, Japan.
Department of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Department of Quantum Life Science, Graduate School of Science and Engineering, Chiba University, Chiba, Japan.

Yuta Y Aoki (YY)

Medical Institute of Developmental Disabilities Research, Showa University, Tokyo, Japan.
Department of Psychiatry, Aoki Clinic, Tokyo, Japan.

Junya Fujino (J)

Medical Institute of Developmental Disabilities Research, Showa University, Tokyo, Japan.
Department of Psychiatry and Behavioral Sciences, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.

Yujiro Yoshihara (Y)

Department of Psychiatry, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

Motoaki Nakamura (M)

Medical Institute of Developmental Disabilities Research, Showa University, Tokyo, Japan.

Ryuta Aoki (R)

Medical Institute of Developmental Disabilities Research, Showa University, Tokyo, Japan.
Department of Language Sciences, Tokyo Metropolitan University, Tokyo, Japan.

Tsukasa Okimura (T)

Medical Institute of Developmental Disabilities Research, Showa University, Tokyo, Japan.

Haruhisa Ohta (H)

Medical Institute of Developmental Disabilities Research, Showa University, Tokyo, Japan.

Yuki Sakai (Y)

Brain Information Communication Research Laboratory Group, Advanced Telecommunications Research Institute International, Kyoto, Japan.
XNef, Inc., Kyoto, Japan.

Masahiro Takamura (M)

Department of Psychiatry and Neurosciences, Hiroshima University, Hiroshima, Japan.
Department of Neurology, Shimane University, Shimane, Japan.

Naho Ichikawa (N)

Department of Psychiatry and Neurosciences, Hiroshima University, Hiroshima, Japan.

Go Okada (G)

Department of Psychiatry and Neurosciences, Hiroshima University, Hiroshima, Japan.

Naohiro Okada (N)

Department of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
The International Research Center for Neurointelligence (WPI-IRCN) at The University of Tokyo Institutes for Advanced Study (UTIAS), The University of Tokyo, Tokyo, Japan.

Kiyoto Kasai (K)

Department of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
The International Research Center for Neurointelligence (WPI-IRCN) at The University of Tokyo Institutes for Advanced Study (UTIAS), The University of Tokyo, Tokyo, Japan.
UTokyo Institute for Diversity and Adaptation of Human Mind (UTIDAHM), The University of Tokyo, Tokyo, Japan.

Saori C Tanaka (SC)

Brain Information Communication Research Laboratory Group, Advanced Telecommunications Research Institute International, Kyoto, Japan.
Division of Information Science, Nara Institute of Science and Technology, Nara, Japan.

Hiroshi Imamizu (H)

Brain Information Communication Research Laboratory Group, Advanced Telecommunications Research Institute International, Kyoto, Japan.
Department of Psychology, Graduate School of Humanities and Sociology, The University of Tokyo, Tokyo, Japan.

Nobumasa Kato (N)

Medical Institute of Developmental Disabilities Research, Showa University, Tokyo, Japan.

Yasumasa Okamoto (Y)

Department of Psychiatry and Neurosciences, Hiroshima University, Hiroshima, Japan.

Hidehiko Takahashi (H)

Department of Psychiatry and Behavioral Sciences, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan.
Department of Psychiatry, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Center for Brain Integration Research, Tokyo Medical and Dental University, Tokyo, Japan.

Mitsuo Kawato (M)

Brain Information Communication Research Laboratory Group, Advanced Telecommunications Research Institute International, Kyoto, Japan.
XNef, Inc., Kyoto, Japan.

Okito Yamashita (O)

Brain Information Communication Research Laboratory Group, Advanced Telecommunications Research Institute International, Kyoto, Japan.
Center for Advanced Intelligence Project, RIKEN, Tokyo, Japan.

Ryu-Ichiro Hashimoto (RI)

Medical Institute of Developmental Disabilities Research, Showa University, Tokyo, Japan. dbridges50@gmail.com.
Brain Information Communication Research Laboratory Group, Advanced Telecommunications Research Institute International, Kyoto, Japan. dbridges50@gmail.com.
Department of Language Sciences, Tokyo Metropolitan University, Tokyo, Japan. dbridges50@gmail.com.

Classifications MeSH